Clinical trials
Hypoglycemia trials in Denmark with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
38 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 2 |
| 2008 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 7 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 5 |
| 2023 | 1 |
| 2024 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 30 |
| Terminated | 3 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Steno Diabetes Center Copenhagen | 10 |
| University of Aarhus | 6 |
| Hillerod Hospital, Denmark | 2 |
| UNEEG Medical A/S | 2 |
| University Hospital, Gentofte, Copenhagen | 2 |
| Amirsalar Samkani | 1 |
| Asger Lund, MD | 1 |
| Bispebjerg Hospital | 1 |
| Bo Feldt-Rasmussen | 1 |
| Central Jutland Regional Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypoglycemia | 38 |
| Diabetes Mellitus, Type 1 | 20 |
| Diabetes Mellitus, Type 2 | 6 |
| Diabetes Mellitus | 5 |
| Hyperglycemia | 5 |
| Cardiovascular Diseases | 2 |
| Glucose Metabolism Disorders | 2 |
| Arrhythmias, Cardiac | 1 |
| Cognitive Dysfunction | 1 |
| Death, Sudden, Cardiac | 1 |
Trials
Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.